Racialized risk environments in a large sample of people who inject drugs in the United States

for the National HIV Behavioral Surveillance Study Group

Producción científicarevisión exhaustiva

53 Citas (Scopus)

Resumen

Background: Substantial racial/ethnic disparities exist in HIV infection among people who inject drugs (PWID) in many countries. To strengthen efforts to understand the causes of disparities in HIV-related outcomes and eliminate them, we expand the "Risk Environment Model" to encompass the construct "racialized risk environments," and investigate whether PWID risk environments in the United States are racialized. Specifically, we investigate whether black and Latino PWID are more likely than white PWID to live in places that create vulnerability to adverse HIV-related outcomes. Methods: As part of the Centers for Disease Control and Prevention's National HIV Behavioral Surveillance, 9170 PWID were sampled from 19 metropolitan statistical areas (MSAs) in 2009. Self-reported data were used to ascertain PWID race/ethnicity. Using Census data and other administrative sources, we characterized features of PWID risk environments at four geographic scales (i.e., ZIP codes, counties, MSAs, and states). Means for each feature of the risk environment were computed for each racial/ethnic group of PWID, and were compared across racial/ethnic groups. Results: Almost universally across measures, black PWID were more likely than white PWID to live in environments associated with vulnerability to adverse HIV-related outcomes. Compared to white PWID, black PWID lived in ZIP codes with higher poverty rates and worse spatial access to substance abuse treatment and in counties with higher violent crime rates. Black PWID were less likely to live in states with laws facilitating sterile syringe access (e.g., laws permitting over-the-counter syringe sales). Latino/white differences in risk environments emerged at the MSA level (e.g., Latino PWID lived in MSAs with higher drug-related arrest rates). Conclusion: PWID risk environments in the US are racialized. Future research should explore the implications of this racialization for racial/ethnic disparities in HIV-related outcomes, using appropriate methods.

Idioma originalEnglish
Páginas (desde-hasta)43-55
Número de páginas13
PublicaciónInternational Journal of Drug Policy
Volumen27
DOI
EstadoPublished - ene. 1 2016

Financiación

This research was supported by two NIH grants: “ Place Characteristics & Disparities in HIV in IDUS: A Multilevel Analysis of NHBS ” ( DA035101 ; Cooper, PI) and the Emory Center for AIDS Research ( P30 AI050409 ; Curran, PI). It was also supported by the Centers and Disease Control and Prevention, and the National HIV Behavioral Surveillance Study Group: Atlanta, GA: Jennifer Taussig, Shacara Johnson, Jeff Todd; Baltimore, MD: Colin Flynn, Danielle German; Boston, MA: Debbie Isenberg, Maura Driscoll, Elizabeth Hurwitz; Chicago, IL: Nikhil Prachand, Nanette Benbow; Dallas, TX: Sharon Melville, Richard Yeager, Jim Dyer, Alicia Novoa; Denver, CO: Mark Thrun, Alia Al-Tayyib; Detroit, MI: Emily Higgins, Eve Mokotoff, Vivian Griffin; Houston, TX: Aaron Sayegh, Jan Risser, Hafeez Rehman; Los Angeles, CA: Trista Bingham, Ekow Kwa Sey; Miami, FL: Lisa Metsch, David Forrest, Dano Beck, Gabriel Cardenas; Nassau-Suffolk, NY: Chris Nemeth, Lou Smith, Carol-Ann Watson; New Orleans, LA: William T. Robinson, DeAnn Gruber, Narquis Barak; New York City, NY: Alan Neaigus, Samuel Jenness, Travis Wendel, Camila Gelpi-Acosta, Holly Hagan; Newark, NJ: Henry Godette, Barbara Bolden, Sally D’Errico; Philadelphia, PA: Kathleen A. Brady, Althea Kirkland, Mark Shpaner; San Diego, CA: Vanessa Miguelino-Keasling, Al Velasco; San Francisco, CA: H. Fisher Raymond; San Juan, PR: Sandra Miranda De León, Yadira Rolón-Colón; Seattle, WA: Maria Courogen, Hanne Thiede, Richard Burt; St Louis, MO: Michael Herbert, Yelena Friedberg, Dale Wrigley, Jacob Fisher; Washington, DC: Marie Sansone, Tiffany West-Ojo, Manya Magnus, Irene Kuo; Behavioral Surveillance Team. We would like to thank the NHBS participants for making this study possible. We also thank and acknowledge Mr. Scott Burris and Ms. Mona Bennett for their help documenting laws governing syringe access.

FinanciadoresNúmero del financiador
Emory Center For AIDS ResearchP30 AI050409
National HIV Behavioral Surveillance Study Group
National Institutes of Health
San Juan
Yadira Rolón-Colón
National Institutes of HealthP30DA011041, P30AI050409
National Institute on Drug AbuseR01DA035101
Centers for Disease Control and Prevention

    ASJC Scopus Subject Areas

    • Medicine (miscellaneous)
    • Health Policy

    Huella

    Profundice en los temas de investigación de 'Racialized risk environments in a large sample of people who inject drugs in the United States'. En conjunto forman una huella única.

    Citar esto